Levy Adam D.
- SEC CIK
- 0002061876
In the past year, 1 open-market purchase filing worth $15.0K and 1 sale filing worth $1.79K.
Current role at each company
- ACRV Acrivon Therapeutics, Inc.Chief Financial Officeras of Aug 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $15.0K
- 1 filing
- Sold
- $1.79K
- 1 filing
- Net
- +$13.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Levy Adam D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 (view filing)4:34 PM ET | Aug 4 | 2 days | Levy Adam D.Chief Financial Officer | SSale | −1.14K | $1.57 | −$1.79K | −1.7%66.0K after | |
| Jan 16, 2026 (view filing) | Jan 14 | 2 days | Levy Adam D.Chief Financial Officer | PPurchase | +8.83K | $1.70 | +$15.0K | +72.7%21.0K after |